ginsenoside rh2 has been researched along with Lung Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J; Song, W; Yang, X; Yin, H; Yu, D; Zhao, D | 1 |
| Ahn, S; Castro-Aceituno, V; Jiménez-Pérez, ZE; Jung, SK; Kim, YJ; Mathiyalagan, R; Simu, SY; Subramaniyam, S; Wang, C; Yang, DC | 1 |
| Chen, Y; Dong, X; Song, W; Tan, M; Zhang, Y | 2 |
| Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
| Fan, C; Guo, M; Li, P; Ling, Y; Qu, D; Zhou, T; Zhou, X | 1 |
| Cai, H; Ge, G; Yan, Y | 1 |
| Chen, M; Fang, Z; Huang, N; Li, H; Li, Y; Luo, Y; Teng, W; Tian, J; Wu, J; Yang, X; Zhu, W | 1 |
| Bai, G; Guo, Y; Hou, Y; Jiang, M; Jiang, Z; Jiao, Y; Kim, U; Li, C; Ma, X; Wang, Z | 1 |
| Huang, R; Li, L; Li, S; Qian, B; Qian, Y; Tian, C; Wang, B; Xiang, M; Xie, R; Yang, J; Zhang, Z | 1 |
| Li, S; Liu, X; Qi, X; Sun, Y; Yang, Y; Yu, H; Yue, L; Zhang, C; Zhao, H | 1 |
| Hu, CP; Hu, S; Xiong, LJ; Yu, JY; Zhang, YX | 1 |
| An, IS; An, S; Bae, S; Kim, YJ; Kwon, KJ | 1 |
| Chang, WM; Chen, JC; Cheng, CC; Hsu, SL; Huang, CY; Yang, SM | 1 |
| Hu, CP; Hu, S; Liang, CH | 1 |
| Hu, CP; Liang, S; Yang, HZ; Zhou, DB | 1 |
16 other study(ies) available for ginsenoside rh2 and Lung Neoplasms
| Article | Year |
|---|---|
Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
Topics: Adenocarcinoma of Lung; beta Catenin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Luciferases; Lung Neoplasms; MicroRNAs; Protein Serine-Threonine Kinases; Wnt Signaling Pathway | 2023 |
Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Delivery Systems; Ginsenosides; Humans; Inflammation; Lung Neoplasms; Macrophages; Mice; Polyethylene Glycols; RAW 264.7 Cells | 2019 |
Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; B7-H1 Antigen; Cisplatin; Drug Synergism; Drugs, Chinese Herbal; Ginsenosides; Humans; Lung Neoplasms; Superoxides | 2020 |
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2.
Topics: A549 Cells; Ginsenosides; Humans; Lung Neoplasms; Micelles; Pentacyclic Triterpenes; Polyethylene Glycols; Triterpenes | 2017 |
Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells.
Topics: Acetylcysteine; Activating Transcription Factor 4; Apoptosis; Caspases, Initiator; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Ginsenosides; Humans; Lung Neoplasms; Phenylbutyrates; Reactive Oxygen Species; Transcription Factor CHOP; Up-Regulation | 2017 |
Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Movement; Drugs, Chinese Herbal; Female; Ginsenosides; Humans; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C57BL; RAW 264.7 Cells; THP-1 Cells; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Quantitative Proteomics Combined with Affinity MS Revealed the Molecular Mechanism of Ginsenoside Antitumor Effects.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Survival; Ginsenosides; Guanosine Triphosphate; Humans; Lung Neoplasms; Molecular Docking Simulation; Neoplasm Proteins; Protein Binding; Protein Conformation; Proteomics; ras Proteins; Sapogenins | 2019 |
Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Fatty Acid Synthase, Type I; Fatty Acids; Ginsenosides; Humans; Immune Tolerance; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Sterol Regulatory Element Binding Protein 1; Xenograft Model Antitumor Assays | 2019 |
Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia
Topics: A549 Cells; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Movement; Ginsenosides; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; MicroRNAs | 2019 |
JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Topics: A549 Cells; Activating Transcription Factor 2; Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Caspase 8; Cell Growth Processes; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Ginsenosides; Humans; Lung Neoplasms; MAP Kinase Signaling System; Transcription Factor AP-1 | 2016 |
[Research on the mechanism of ginsenoside Rh2 reversing the resistance of lung adenocarcinoma cells to cisplatin].
Topics: Adenocarcinoma; Apoptosis; Calcium; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Ginsenosides; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial | 2010 |
Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chi-Square Distribution; Computational Biology; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Lung Neoplasms; MicroRNAs; Oligonucleotide Array Sequence Analysis; Statistics, Nonparametric; Up-Regulation | 2013 |
Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; G1 Phase; Ginsenosides; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Time Factors | 2005 |
[Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Ginsenosides; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Panax; Random Allocation; Technetium Tc 99m Sestamibi | 2005 |
[Effect of ginsenoside Rh2 on immunocompetence of alveolar macrophages in patients with non-small cell lung cancer].
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Carcinoma, Non-Small-Cell Lung; Female; Ginsenosides; Humans; Lung Neoplasms; Macrophages, Alveolar; Male; Middle Aged; Nitric Oxide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2007 |